Life Insurance for Cardiomyopathy
At Diversified Insurance Brokers, we specialize in helping individuals with cardiomyopathy secure life insurance coverage—even when they’ve been declined by other carriers. Heart conditions often trigger automatic declines or inflated premiums when applications are submitted without strategy. With decades of high-risk underwriting experience and access to more than 100 top-rated life insurance carriers, we know which companies are most flexible, how cardiomyopathy is evaluated behind the scenes, and how to present your medical history in a way that leads to real offers.
Cardiomyopathy is not a single diagnosis, but a broad category of heart muscle disorders with widely different risk profiles. Because of this, underwriting outcomes vary significantly from one applicant to the next. Someone with stable, well-managed cardiomyopathy may still qualify for traditional term or permanent life insurance, while others with more advanced disease may need specialized solutions. Our role is to determine where you fall on that spectrum before an application ever reaches an underwriter.
Life Insurance with Cardiomyopathy
A diagnosis of cardiomyopathy does not automatically make you uninsurable. At Diversified Insurance Brokers, we help clients with heart conditions find coverage that reflects medical stability, proper management, and real-world risk—not worst-case assumptions.
Speak with an advisor experienced in life insurance underwriting for complex cardiac conditions.
How Cardiomyopathy Is Evaluated for Life Insurance
Life insurance companies evaluate cardiomyopathy with a much deeper level of scrutiny than many applicants expect. The diagnosis alone is not enough to determine insurability. Instead, underwriters focus on how the condition affects heart function over time, how well it is controlled, and whether it has led to complications such as heart failure, arrhythmias, or hospitalizations.
The specific type of cardiomyopathy matters greatly. Dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy all carry different risk profiles. Underwriters also look closely at the underlying cause—whether the condition is genetic, related to hypertension or coronary artery disease, viral in origin, or associated with a prior cardiac event.
One of the most important metrics insurers review is left ventricular ejection fraction (EF). EF provides a snapshot of how efficiently the heart is pumping blood. Stable or improving EF readings over time are a strong positive factor, while declining or severely reduced EF often leads to higher ratings or limited options.
Symptoms, Stability, and Medical Management
Beyond test results, insurers assess how cardiomyopathy affects daily life. Symptoms such as shortness of breath, fatigue, chest pain, dizziness, or fainting episodes can indicate disease progression. Applicants who are asymptomatic or minimally symptomatic under consistent cardiology care generally present a much stronger case.
Treatment and compliance also play a critical role. Regular cardiology follow-ups, consistent medication use, and documented stability over time signal good disease management. The presence of implanted devices such as pacemakers or implantable cardioverter defibrillators (ICDs) does not automatically disqualify an applicant, but it does change how the case must be positioned.
Who Life Insurance with Cardiomyopathy Is Best Suited For
Life insurance after a cardiomyopathy diagnosis is most achievable for individuals whose condition is stable and well monitored. This often includes applicants with moderate EF levels that have remained consistent, no recent hospital admissions, and no significant progression in symptoms.
We frequently help people who have already been declined elsewhere. Declines often occur when applications are submitted without context or sent to carriers that take a conservative stance on cardiac risk. A strategic approach—paired with updated test results—can make a meaningful difference in outcomes.
What Improves Underwriting Outcomes
Several factors consistently improve the quality of life insurance offers for applicants with cardiomyopathy. Demonstrated stability in ejection fraction, especially over multiple years, is one of the strongest indicators. Absence of recent emergency room visits, hospitalizations, or acute cardiac events also weighs heavily in an applicant’s favor.
Lifestyle factors matter as well. Non-smoker status, well-controlled blood pressure, healthy cholesterol levels, and adherence to treatment plans all help counterbalance the diagnosis. Clear, organized medical documentation allows underwriters to see the full picture rather than making assumptions based on limited data.
Typical Policy Outcomes We See
For mild or stable cases, traditional term life insurance or permanent policies may be available, sometimes at standard or mildly rated premiums. Applicants with moderate cardiomyopathy who show improvement or long-term stability are often insurable at table-rated levels that still provide meaningful coverage.
In more advanced or unstable cases, traditional underwriting may not be available. In those situations, we explore alternative solutions such as guaranteed issue or graded benefit policies that still provide protection without medical underwriting.
No two cardiomyopathy cases are identical. Our role is to match your specific medical profile with the carriers most likely to view it favorably.
Why Work With Diversified Insurance Brokers
Cardiac underwriting is one of the most technical areas of life insurance. At Diversified Insurance Brokers, we pre-screen cardiomyopathy cases, identify receptive carriers, and control how medical information is presented. This prevents unnecessary declines and helps preserve future insurability.
Because we are independent and work with more than 100 A-rated insurers, we are not limited to a single underwriting philosophy. Our clients benefit from a confidential, streamlined process where records are gathered once and strategically marketed to the right companies.
Example Case
A 60-year-old non-smoker with dilated cardiomyopathy and an ejection fraction of 45% came to us after being declined by two insurers. He had no recent hospitalizations and consistent cardiology follow-ups. By positioning his case with a carrier known for flexibility in moderate cardiac profiles, we secured a $250,000 10-year term policy at a manageable table rating—saving him more than $600 per year compared to prior offers.
Related Pages
Talk With an Advisor Today
Choose how you’d like to connect—call or message us, then book a time that works for you.
Schedule here:
calendly.com/jason-dibcompanies/diversified-quotes
Licensed in all 50 states • Fiduciary, family-owned since 1980
FAQs: Life Insurance for Cardiomyopathy
Can I get life insurance if I have cardiomyopathy?
Yes. Many people with cardiomyopathy are still insurable. Approval depends on factors such as the type of cardiomyopathy, ejection fraction, symptom stability, treatment history, and how well the condition is managed over time.
What types of cardiomyopathy do insurers look at differently?
Insurers evaluate dilated, hypertrophic, restrictive, and arrhythmogenic cardiomyopathy differently. Each has a unique risk profile, and underwriting decisions depend heavily on severity, progression, and associated complications.
How important is ejection fraction (EF) in underwriting?
Ejection fraction is one of the most important underwriting factors. Stable or improving EF readings over time generally lead to better outcomes, while severely reduced or declining EF can limit traditional coverage options.
Does having a pacemaker or ICD automatically cause a decline?
No. Having a pacemaker or implantable cardioverter defibrillator does not automatically disqualify you. Insurers focus on why the device was placed, how often it has activated, and whether your condition has remained stable.
How long does my condition need to be stable before applying?
Most carriers prefer to see at least 6–12 months of stability, with no recent hospitalizations or major cardiac events. Longer periods of documented stability can significantly improve approval chances.
What policy types are usually available for cardiomyopathy?
Depending on severity, applicants may qualify for term life, permanent life (whole or universal), table-rated policies, or in more advanced cases, guaranteed or graded benefit coverage.
Why use a broker instead of applying directly?
High-risk cardiac cases require careful carrier selection and medical presentation. An experienced broker helps avoid unnecessary declines, targets more flexible insurers, and improves the likelihood of competitive offers.
About the Author:
Jason Stolz, CLTC, CRPC, is a senior insurance and retirement professional with more than two decades of real-world experience helping individuals, families, and business owners protect their income, assets, and long-term financial stability. As a long-time partner of the nationally licensed independent agency Diversified Insurance Brokers, Jason provides trusted guidance across multiple specialties—including fixed and indexed annuities, long-term care planning, personal and business disability insurance, life insurance solutions, and short-term health coverage. Diversified Insurance Brokers maintains active contracts with over 100 highly rated insurance carriers, ensuring clients have access to a broad and competitive marketplace.
His practical, education-first approach has earned recognition in publications such as VoyageATL, highlighting his commitment to financial clarity and client-focused planning. Drawing on deep product knowledge and years of hands-on field experience, Jason helps clients evaluate carriers, compare strategies, and build retirement and protection plans that are both secure and cost-efficient.
